Add to ORKGBackground: The Acinetobacter species, particularly A. baumannii, has emerged as one of the main causes of nosocomial infections in recent years. The high prevalence of drug resistance in A. baumannii limits the therapeutic options for treating infections caused by these bacteria. The objective of this study was to determine the in vitro activity of Tigecycline and Colistin against clinical isolates of A. baumannii in Tehran and Bandar Abbas, Iran
Introduction: Antibiotic resistance is an important issue that may worsen the clinical evolution of ...
Acinetobacter baumannii is a major cause of nosocomial infections worldwide. Therapeutic optionsin m...
ABSTRACT: The incidence of multidrug-resistant Acinetobacter baumannii (MDR A. baumannii) is increas...
Background: The Acinetobacter species, particularly A. baumannii, has emerged as one of the main cau...
Raziyeh Kheshti,1 Bahman Pourabbas,2 Maryam Mosayebi,3 Afsaneh Vazin1 1Department of Clinical Pharm...
The In vitro susceptibility of clinical and environmental isolates of Acinetobacter baumannii to tig...
Acinetobacter baumannii has emerged as one of the most important nosocomial patho- gens and mul...
In vitro activity of tigecycline against 148 strains of Acinetobacter baumannii isolated from differ...
Background: Colistin is being increasingly used for treatment of infections caused by multidrug-resi...
Background: In a recent multi-centre Italian survey (2003-2004), conducted in 45 laboratories throug...
Abstract Background In a recent multi-centre Italian survey (2003–2004), conducted in 45 laboratorie...
Background: The members of the genus Acinetobacter are Gram-negative cocobacilli that are frequently...
Aims: Acinetobacter species usually affect hospitalized patients and are involved in many infections...
Background: Acinetobacter is a multi-drug resistant and nosocomial pathogen. The aim of this study w...
Background: Colistin is being increasingly used for treatment of infections caused by multidrug-resi...
Introduction: Antibiotic resistance is an important issue that may worsen the clinical evolution of ...
Acinetobacter baumannii is a major cause of nosocomial infections worldwide. Therapeutic optionsin m...
ABSTRACT: The incidence of multidrug-resistant Acinetobacter baumannii (MDR A. baumannii) is increas...
Background: The Acinetobacter species, particularly A. baumannii, has emerged as one of the main cau...
Raziyeh Kheshti,1 Bahman Pourabbas,2 Maryam Mosayebi,3 Afsaneh Vazin1 1Department of Clinical Pharm...
The In vitro susceptibility of clinical and environmental isolates of Acinetobacter baumannii to tig...
Acinetobacter baumannii has emerged as one of the most important nosocomial patho- gens and mul...
In vitro activity of tigecycline against 148 strains of Acinetobacter baumannii isolated from differ...
Background: Colistin is being increasingly used for treatment of infections caused by multidrug-resi...
Background: In a recent multi-centre Italian survey (2003-2004), conducted in 45 laboratories throug...
Abstract Background In a recent multi-centre Italian survey (2003–2004), conducted in 45 laboratorie...
Background: The members of the genus Acinetobacter are Gram-negative cocobacilli that are frequently...
Aims: Acinetobacter species usually affect hospitalized patients and are involved in many infections...
Background: Acinetobacter is a multi-drug resistant and nosocomial pathogen. The aim of this study w...
Background: Colistin is being increasingly used for treatment of infections caused by multidrug-resi...
Introduction: Antibiotic resistance is an important issue that may worsen the clinical evolution of ...
Acinetobacter baumannii is a major cause of nosocomial infections worldwide. Therapeutic optionsin m...
ABSTRACT: The incidence of multidrug-resistant Acinetobacter baumannii (MDR A. baumannii) is increas...